Deletion of alpha-synuclein decreases impulsivity in mice

Genes, Brain and Behavior

Volumn 11, Issue 2, 2012, Pages 137-146

  Pena Oliver Y ^a   Buchman, V L ^b   Dalley, J W ^c,d   Robbins, T W ^c   Schumann, G ^e   Ripley, T L ^a   King, S L ^a   Stephens, D N ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alpha synuclein; Impulse control disorders; Impulsivity; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; MESSENGER RNA; MULTIMERIN 1; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME DELETION; CONTROLLED STUDY; DECISION MAKING; GENE DELETION; GENE EXPRESSION; GENETIC RECOMBINATION; HIPPOCAMPUS; IMPULSIVENESS; MALE; MOTOR PERFORMANCE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPONSE TIME; STIMULUS RESPONSE; STRAIN DIFFERENCE; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; BEHAVIOR, ANIMAL; DECISION MAKING; GAMMA-SYNUCLEIN; HIPPOCAMPUS; IMPULSIVE BEHAVIOR; MALE; MICE; MICE, KNOCKOUT; REACTION TIME;

MUS;

EID: 84856356321     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2011.00758.x     Document Type: Article

References (57)

1. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P.E., Shinsky, N., Verdugo, J.M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D. & Rosenthal, A. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252.
2. Ambermoon, P., Carter, A., Hall, W.D., Dissanayaka, N.N. & O'Sullivan, J.D. (2010) Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction (Abingdon, England) 106, 283-293.
3. Anwar, S., Peters, O., Millership, S., Ninkina, N., Doig, N., Connor-Robson, N., Threlfell, S., Kooner, G., Deacon, R.M., Bannerman, D.M., Bolam, J.P., Chandra, S.S., Cragg, S.J., Wade-Martins, R. & Buchman, V.L. (2011) Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J Neurosci 31, 7264-7274.
4. Boyer, F. & Dreyer, J.L. (2007) Alpha-synuclein in the nucleus accumbens induces changes in cocaine behaviour in rats. The European journal of neuroscience 26, 2764-2776.
5. Brenz Verca, M.S., Bahi, A., Boyer, F., Wagner, G.C. & Dreyer, J.L. (2003) Distribution of alpha- and gamma-synucleins in the adult rat brain and their modification by high-dose cocaine treatment. The European journal of neuroscience 18, 1923-1938.
6. Burre, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M.R. & Sudhof, T.C. (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science (New York, NY) 329, 1663-1667.
7. Carli, M., Robbins, T.W., Evenden, J.L. & Everitt, B.J. (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behavioural brain research 9, 361-380.
8. Chandra, S., Fornai, F., Kwon, H.B., Yazdani, U., Atasoy, D., Liu, X., Hammer, R.E., Battaglia, G., German, D.C., Castillo, P.E. & Sudhof, T.C. (2004) Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci USA 101, 14966-14971.
9. Chartier-Harlin, M.C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., Waucquier, N., Defebvre, L., Amouyel, P., Farrer, M. & Destee, A. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167-1169.
10. Chesler, E.J., Wang, J., Lu, L., Qu, Y., Manly, K.F. & Williams, R.W. (2003) Genetic correlates of gene expression in recombinant inbred strains: a relational model system to explore neurobehavioral phenotypes. Neuroinformatics 1, 343-357.
11. Dagher, A. & Robbins, T.W. (2009) Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 61, 502-510.
12. Dalley, J.W., Fryer, T.D., Brichard, L., Robinson, E.S., Theobald, D.E., Laane, K., Pena, Y., Murphy, E.R., Shah, Y., Probst, K., Abakumova, I., Aigbirhio, F.I., Richards, H.K., Hong, Y., Baron, J.C., Everitt, B.J. & Robbins, T.W. (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (New York, N.Y.) 315, 1267-1270.
13. Dalley, J.W., Everitt, B.J. & Robbins, T.W. (2011) Impulsivity, compulsivity, and top-down cognitive control. Neuron 69, 680-694.
14. Dawe, S. & Loxton, N.J. (2004) The role of impulsivity in the development of substance use and eating disorders. Neuroscience and Biobehavioral Reviews 28, 343-351.
15. Evans, A.H., Lawrence, A.D., Potts, J., Appel, S. & Lees, A.J. (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65, 1570-1574.
16. Evans, A.H., Strafella, A.P., Weintraub, D. & Stacy, M. (2009) Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 24, 1561-1570.
17. Evenden, J.L. (1999) Varieties of impulsivity. Psychopharmacology 146, 348-361.
18. Fornai, F., Lenzi, P., Ferrucci, M., Lazzeri, G., di Poggio, A.B., Natale, G., Busceti, C.L., Biagioni, F., Giusiani, M., Ruggieri, S. & Paparelli, A. (2005) Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. Brain Res Bull 65, 405-413.
19. Greten-Harrison, B., Polydoro, M., Morimoto-Tomita, M., Diao, L., Williams, A.M., Nie, E.H., Makani, S., Tian, N., Castillo, P.E., Buchman, V.L. & Chandra, S.S. (2010) alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci USA 107, 19573-19578.
20. Isaias, I.U., Siri, C., Cilia, R., De Gaspari, D., Pezzoli, G. & Antonini, A. (2008) The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 23, 411-415.
21. Ishihara, L. & Brayne, C. (2006) What is the evidence for a premorbid Parkinsonian personality: a systematic review. Mov Disord 21, 1066-1072.
22. Jakes, R., Spillantini, M.G. & Goedert, M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345, 27-32.
23. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. & Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genet 18, 106-108.
24. Kuhn, M., Haebig, K., Bonin, M., Ninkina, N., Buchman, V.L., Poths, S. & Riess, O. (2007) Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein. Neurogenetics 8, 71-81.
25. Lawrence, A.J., Blackwell, A.D., Barker, R.A., Spagnolo, F., Clark, L., Aitken, M.R. & Sahakian, B.J. (2007) Predictors of punding in Parkinson's disease: results from a questionnaire survey. Mov Disord 22, 2339-2345.
26. Mash, D.C., Ouyang, Q., Pablo, J., Basile, M., Izenwasser, S., Lieberman, A. & Perrin, R.J. (2003) Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. J Neurosci 23, 2564-2571.
27. Menza, M. (2000) The personality associated with Parkinson's disease. Curr Psychiatry Rep 2, 421-426.
28. Murphy, D.D., Rueter, S.M., Trojanowski, J.Q. & Lee, V.M. (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20, 3214-3220.
29. Nakajo, S., Tsukada, K., Omata, K., Nakamura, Y. & Nakaya, K. (1993) A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem/FEBS 217, 1057-1063.
30. Nemani, V.M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M.K., Chaudhry, F.A., Nicoll, R.A. & Edwards, R.H. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79.
31. Oliver, Y.P., Ripley, T.L. & Stephens, D.N. (2009) Ethanol effects on impulsivity in two mouse strains: similarities to diazepam and ketamine. Psychopharmacology 204, 679-692.
32. Overall, R.W., Kempermann, G., Peirce, J., Lu, L., Goldowitz, D., Gage, F.H., Goodwin, S., Smit, A.B., Airey, D.C., Rosen, G.D., Schalkwyk, L.C., Sutter, T.R., Nowakowski, R.S., Whatley, S. & Williams, R.W. (2009) Genetics of the hippocampal transcriptome in mouse: a systematic survey and online neurogenomics resource. Front Neurosci 3, 55.
33. Patel, S., Stolerman, I.P., Asherson, P. & Sluyter, F. (2006) Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behav Brain Res 170, 197-203.
34. Paulson, G.W. & Dadmehr, N. (1991) Is there a premorbid personality typical for Parkinson's disease? Neurology 41, 73-76.
35. Perry, J.L. & Carroll, M.E. (2008) The role of impulsive behavior in drug abuse. Psychopharmacology 200, 1-26.
36. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45.
37. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I. & Nussbaum, R.L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (New York, N.Y.) 276, 2045-2047.
38. Qin, Y., Ouyang, Q., Pablo, J. & Mash, D.C. (2005) Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport 16, 1489-1493.
39. Robbins, T.W. (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology 163, 362-380.
40. Robertson, D.C., Schmidt, O., Ninkina, N., Jones, P.A., Sharkey, J. & Buchman, V.L. (2004) Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. J Neurochem 89, 1126-1136.
41. Robinson, E.S., Eagle, D.M., Economidou, D., Theobald, D.E., Mar, A.C., Murphy, E.R., Robbins, T.W. & Dalley, J.W. (2009) Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in 'waiting' versus 'stopping'. Behav Brain Res 196, 310-316.
42. Sanchez-Roige, S., Peña-Oliver, Y. & Stephens, D.N. (in press) Measuring Impulsivity in mice: the 5-Choice serial reaction time task. Psychopharmacology (in press).
43. Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., Tomiyama, H., Nakashima, K., Hasegawa, K., Obata, F., Yoshikawa, T., Kawakami, H., Sakoda, S., Yamamoto, M., Hattori, N., Murata, M., Nakamura, Y. & Toda, T. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41, 1303-1307.
44. Senior, S.L., Ninkina, N., Deacon, R., Bannerman, D., Buchman, V.L., Cragg, S.J. & Wade-Martins, R. (2008) Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. The Eur J Neuroscience 27, 947-957.
45. Singleton, A.B., Farrer, M., Johnson, J. et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science (New York, N.Y.) 302, 841.
46. Specht, C.G. & Schoepfer, R. (2001) Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci, 2, 11.
47. Specht, C.G. & Schoepfer, R. (2004) Deletion of multimerin-1 in alpha-synuclein-deficient mice. Genomics 83, 1176-1178.
48. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. & Goedert, M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95, 6469-6473.
49. Steeves, T.D., Miyasaki, J., Zurowski, M., Lang, A.E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S. & Strafella, A.P. (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132, 1376-1385.
50. Todes, C.J. & Lees, A.J. (1985) The pre-morbid personality of patients with Parkinson's disease. J Neurol, Neurosurg, Psychiatry 48, 97-100.
51. Urcelay, G.P. & Dalley, J.W. (2011) Linking ADHD, Impulsivity, and Drug Abuse: A Neuropsychological Perspective. Curr Topics Behav Neurosci. DOI:10.1007/7854_2011_1119.
52. Venda, L.L., Cragg, S.J., Buchman, V.L. & Wade-Martins, R. (2010) alpha-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci 33, 559-568.
53. Vivacqua, G., Casini, A., Vaccaro, R., Fornai, F., Yu, S. & D'Este, L. (2011) Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies. J Chem Neuroanat 41, 97-110.
54. Voon, V., Potenza, M.N. & Thomsen, T. (2007) Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 20, 484-492.
55. Voon, V., Fernagut, P.O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., Juncos, J.L., Obeso, J.A. & Bezard, E. (2009) Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 8, 1140-1149.
56. Walker, S.E., Pena-Oliver, Y. & Stephens, D.N. (2011) Learning not to be impulsive: disruption by experience of alcohol withdrawal. Psychopharmacology 217, 433-442.
57. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., Llorens, V., Gomez Tortosa, E., del Ser, T., Munoz, D.G. & de Yebenes, J.G. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55, 164-173.